Skip to main content
OpenTrials
Completed

NCT Number: NCT06717373

Point-of-Care Echocardiography in Patients With Known or Suspected Aortic Stenosis

This is a prospective clinical trial intended to capture echocardiographic images in patients clinically indicated for an echocardiographic examination using an additional Point of Care Ultrasound device . The images collected will be used to test and possibly validation an AI base Aortic Valve Stenosis algorithm

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Northwestern University

Chicago, Illinois, 60208, United States

About this study

This is a non-randomized, un-blinded single-arm study in patients scheduled for a standard echocardiographic examination. Participants will be scanned by a sonographer (Study Exam) and 6 standard views will be obtained using both the ultrasound systems: PLAX, PSAX-AV, AP4, AP2, AP3 and AP5 .

The patient will undergo their scheduled echocardiographic examination either before or after the study examinations.

The findings from the clinically indicated echocardiographic examination will be used as a gold standard for the presence/absence and severity of aortic stenosis.

The first 45 patients, 15 with mild, 15 with moderate and 15 with severe AS, will be used for testing and possible fine-tuning the AutoAS algorithm for each Study Device, and the remaining up to 155 patients for each Study Device will be used for clinical validation of the algorithm. Because these first 45 patients will only be used for possible fine-tuning the AutoAS algorithm, they will be excluded from endpoint analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients scheduled for an echocardiographic examination
  • Patients ≥18 years old
  • Patient with known or suspected valve disease based on medical history

Exclusion criteria

  • Patients with artificial aortic valves
  • Unable to lie flat for study
  • Patients experiencing a known or suspected acute cardiac event
  • Patients unwilling or unable to give written informed consent

Treatment and study plan

AutoAS

Device

AutoAS is an artificial intelligence algorithm that will be tested retrospectively on the images acquired as part of the study

Primary outcomes

  1. Sensitivity and Specificity

    Time frame: At the time of the examination

    The primary endpoints are the sensitivity and specificity of the Caption AutoAS algorithm for the absence (none/mild AS) or presence (moderate/severe AS) of AS relative to that indicated in the echocardiographic examination.

Secondary outcomes

  1. Subgroup analysis of outcome 1

    Time frame: At the time of the examination

    Subgroup Analyses: Sensitivity and specificity will be calculated for the following sub-groups. BMI group (< 25, ≥ 25-30, ≥ 30), sex, and age (<65, ≥65)

Sponsors and collaborators

Lead sponsor

Caption Health, Inc.

Industry

Registry information

Acronym: POC

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Dec 5, 2024
Registry last updated
Jul 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.